Investing News

Danaher Buys Abcam for $5.7 Billion to Expand Its Product Offerings

Medical tool supplier Danaher moved to expand its product offerings by purchasing British biotech firm Abcam Plc for $5.7 billion, including debt.

Articles You May Like

How Vanguard Index Funds Work
Quantum Leap: 3 Computing Stocks on the Brink of a Breakout
Activist Elliott settles for a new director at Sensata. These next steps may help boost shares
5 Companies Owned by Samsung Electronics
How Does a Blockchain Prevent Double-Spending of Bitcoins?